extracorporeal membrane oxygenation (ecmo)

Displaying 1 study

  • Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients Rochester, MN

    The objective of this study will be to prospectively evaluate the response of a continuous infusion of recombinant human antithrombin concentrate (rhAT) (ATRYN®) to achieve and maintain the AT activity within a specified range in adult patients that require extracorporeal membrane oxygenation (ECMO) following cardiopulmonary bypass (CPB) and cardiac surgery.


Mayo Clinic Footer